Prognostic Biomarkers in Patients with Ovarian Cancer

摘要

The present invention provides methods for assessing an ovarian cancer patient's survival status. Also, methods for evaluating the ovarian cancer state of a patient are described herein. These methods involve the detection, analysis, and classification of biological patterns in biological samples. The biological patterns are obtained using, for example, mass spectrometry systems and other techniques.

主权项

1. A method of determining the prognosis of a subject having or suspected of having ovarian cancer, the method comprising comparing the concentration, expression, peak intensity or level of biomarkers transferrin (TFR) and beta-2 microglobin (B2M) or fragments thereof in a sample from the subject to the level present in a reference, wherein an increased level of said biomarkers relative to the reference is indicative of a poor prognosis.